On March 22, 2023 ArcticZymes Technologies ASA (OSE: AZT) reported that the Board of Directors has today accepted the voluntary resignation of Jethro Holter as Chief Executive Officer, due to personal reasons (Press release, ArcticZymes Technologies, MAR 22, 2023, View Source [SID1234629155]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The resignation will take effect on 30th September 2023 after the required 6 months notice period.

"On behalf of the Board, I want to thank Jethro very much for his outstanding contributions to ArcticZymes over the past 3 years that he has served as our CEO. During that time, Jethro has been instrumental in transforming ArcticZymes into a successful and highly profitable business," said Marie Roskrow. "All of the employees of ArcticZymes send their good wishes and thanks to Jethro."

The Board of Directors will immediately initiate a search for a new CEO. In the meantime, Chairman of the Board, Marie Roskrow, will act as Executive Chairman to lead and support the Company through this transition period.

ArcticZymes also anticipates expanding the Board of Directors in the near future.